Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of dermatology 2022-07, Vol.61 (7), p.e267-e269
Hauptverfasser:	Arroyo‐Andrés, Jorge, Agud‐Dios, Manuel, Rubio‐Muniz, Carmen A., Vico‐Alonso, Cristina, Cortijo‐Cascajares, Susana, Ortiz‐Romero, Pablo L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Brentuximab Vedotin Case reports Humans Immunoconjugates - therapeutic use Ki-1 Antigen Lymphoma Lymphoma, Large-Cell, Anaplastic - diagnosis Lymphoma, Large-Cell, Anaplastic - drug therapy Lymphoma, Large-Cell, Anaplastic - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	e269
container_issue	7
container_start_page	e267
container_title	International journal of dermatology
container_volume	61
creator	Arroyo‐Andrés, Jorge Agud‐Dios, Manuel Rubio‐Muniz, Carmen A. Vico‐Alonso, Cristina Cortijo‐Cascajares, Susana Ortiz‐Romero, Pablo L.
description
doi_str_mv	10.1111/ijd.15834
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2676424873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2676424873</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3204-87c29c329dd94ac544ff82070340213d618d68c41f55ff0c9fd79442df88d2313</originalsourceid><addsrcrecordid>eNp1kLtOwzAUQC0EoqUw8APIEhNDWr_yYkPlVYQEA8yR6wdN5SbBdigZkPgEvpEvwZDChpfrKx0dXR0ADjEa4_Am5VKOcZxRtgWGmCZxxBJKtsEQIYyjHMX5AOw5twwrJZjtggFlNKEJpkPwdm_LFbcdFK3nlapbB3nFG8OdLwU03D6pz_cPoYyBpls1i3rFoWuFUM7p1pgOequ4VxKuS7-AZeUtN8qVdcUNnFtV-fY1-OfwRcnal9Up5FBwp6BVTW39PtjR3Dh1sJkj8Hh58TC9jm7vrmbTs9tIUIJYlKWC5OGbS5kzLmLGtM4IShFliGAqE5zJJBMM6zjWGolcyzRnjEidZZJQTEfguPc2tn5ulfPFsm5tuNEVJEkTRliW0kCd9JSwtXNW6aLp4xQYFd-hixC6-Akd2KONsZ2vlPwjf8sGYNID69Ko7n9TMbs575VfJXiKVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2676424873</pqid></control><display><type>article</type><title>Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Arroyo‐Andrés, Jorge ; Agud‐Dios, Manuel ; Rubio‐Muniz, Carmen A. ; Vico‐Alonso, Cristina ; Cortijo‐Cascajares, Susana ; Ortiz‐Romero, Pablo L.</creator><creatorcontrib>Arroyo‐Andrés, Jorge ; Agud‐Dios, Manuel ; Rubio‐Muniz, Carmen A. ; Vico‐Alonso, Cristina ; Cortijo‐Cascajares, Susana ; Ortiz‐Romero, Pablo L.</creatorcontrib><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.15834</identifier><identifier>PMID: 34363613</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Brentuximab Vedotin ; Case reports ; Humans ; Immunoconjugates - therapeutic use ; Ki-1 Antigen ; Lymphoma ; Lymphoma, Large-Cell, Anaplastic - diagnosis ; Lymphoma, Large-Cell, Anaplastic - drug therapy ; Lymphoma, Large-Cell, Anaplastic - pathology</subject><ispartof>International journal of dermatology, 2022-07, Vol.61 (7), p.e267-e269</ispartof><rights>2021</rights><rights>International Journal of Dermatology © 2022 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3204-87c29c329dd94ac544ff82070340213d618d68c41f55ff0c9fd79442df88d2313</citedby><cites>FETCH-LOGICAL-c3204-87c29c329dd94ac544ff82070340213d618d68c41f55ff0c9fd79442df88d2313</cites><orcidid>0000-0003-2985-9639 ; 0000-0003-0835-9301</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.15834$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.15834$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34363613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arroyo‐Andrés, Jorge</creatorcontrib><creatorcontrib>Agud‐Dios, Manuel</creatorcontrib><creatorcontrib>Rubio‐Muniz, Carmen A.</creatorcontrib><creatorcontrib>Vico‐Alonso, Cristina</creatorcontrib><creatorcontrib>Cortijo‐Cascajares, Susana</creatorcontrib><creatorcontrib>Ortiz‐Romero, Pablo L.</creatorcontrib><title>Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><subject>Brentuximab Vedotin</subject><subject>Case reports</subject><subject>Humans</subject><subject>Immunoconjugates - therapeutic use</subject><subject>Ki-1 Antigen</subject><subject>Lymphoma</subject><subject>Lymphoma, Large-Cell, Anaplastic - diagnosis</subject><subject>Lymphoma, Large-Cell, Anaplastic - drug therapy</subject><subject>Lymphoma, Large-Cell, Anaplastic - pathology</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOwzAUQC0EoqUw8APIEhNDWr_yYkPlVYQEA8yR6wdN5SbBdigZkPgEvpEvwZDChpfrKx0dXR0ADjEa4_Am5VKOcZxRtgWGmCZxxBJKtsEQIYyjHMX5AOw5twwrJZjtggFlNKEJpkPwdm_LFbcdFK3nlapbB3nFG8OdLwU03D6pz_cPoYyBpls1i3rFoWuFUM7p1pgOequ4VxKuS7-AZeUtN8qVdcUNnFtV-fY1-OfwRcnal9Up5FBwp6BVTW39PtjR3Dh1sJkj8Hh58TC9jm7vrmbTs9tIUIJYlKWC5OGbS5kzLmLGtM4IShFliGAqE5zJJBMM6zjWGolcyzRnjEidZZJQTEfguPc2tn5ulfPFsm5tuNEVJEkTRliW0kCd9JSwtXNW6aLp4xQYFd-hixC6-Akd2KONsZ2vlPwjf8sGYNID69Ko7n9TMbs575VfJXiKVQ</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Arroyo‐Andrés, Jorge</creator><creator>Agud‐Dios, Manuel</creator><creator>Rubio‐Muniz, Carmen A.</creator><creator>Vico‐Alonso, Cristina</creator><creator>Cortijo‐Cascajares, Susana</creator><creator>Ortiz‐Romero, Pablo L.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0003-2985-9639</orcidid><orcidid>https://orcid.org/0000-0003-0835-9301</orcidid></search><sort><creationdate>202207</creationdate><title>Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report</title><author>Arroyo‐Andrés, Jorge ; Agud‐Dios, Manuel ; Rubio‐Muniz, Carmen A. ; Vico‐Alonso, Cristina ; Cortijo‐Cascajares, Susana ; Ortiz‐Romero, Pablo L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3204-87c29c329dd94ac544ff82070340213d618d68c41f55ff0c9fd79442df88d2313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Brentuximab Vedotin</topic><topic>Case reports</topic><topic>Humans</topic><topic>Immunoconjugates - therapeutic use</topic><topic>Ki-1 Antigen</topic><topic>Lymphoma</topic><topic>Lymphoma, Large-Cell, Anaplastic - diagnosis</topic><topic>Lymphoma, Large-Cell, Anaplastic - drug therapy</topic><topic>Lymphoma, Large-Cell, Anaplastic - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arroyo‐Andrés, Jorge</creatorcontrib><creatorcontrib>Agud‐Dios, Manuel</creatorcontrib><creatorcontrib>Rubio‐Muniz, Carmen A.</creatorcontrib><creatorcontrib>Vico‐Alonso, Cristina</creatorcontrib><creatorcontrib>Cortijo‐Cascajares, Susana</creatorcontrib><creatorcontrib>Ortiz‐Romero, Pablo L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arroyo‐Andrés, Jorge</au><au>Agud‐Dios, Manuel</au><au>Rubio‐Muniz, Carmen A.</au><au>Vico‐Alonso, Cristina</au><au>Cortijo‐Cascajares, Susana</au><au>Ortiz‐Romero, Pablo L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2022-07</date><risdate>2022</risdate><volume>61</volume><issue>7</issue><spage>e267</spage><epage>e269</epage><pages>e267-e269</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>34363613</pmid><doi>10.1111/ijd.15834</doi><tpages>276</tpages><orcidid>https://orcid.org/0000-0003-2985-9639</orcidid><orcidid>https://orcid.org/0000-0003-0835-9301</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 0011-9059
ispartof	International journal of dermatology, 2022-07, Vol.61 (7), p.e267-e269
issn	0011-9059 1365-4632
language	eng
recordid	cdi_proquest_journals_2676424873
source	Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects	Brentuximab Vedotin Case reports Humans Immunoconjugates - therapeutic use Ki-1 Antigen Lymphoma Lymphoma, Large-Cell, Anaplastic - diagnosis Lymphoma, Large-Cell, Anaplastic - drug therapy Lymphoma, Large-Cell, Anaplastic - pathology
title	Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T20%3A15%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20cutaneous%20anaplastic%20large%E2%80%90cell%20lymphoma%20successfully%20treated%20with%20intralesional%20brentuximab%20vedotin:%20a%20case%20report&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Arroyo%E2%80%90Andr%C3%A9s,%20Jorge&rft.date=2022-07&rft.volume=61&rft.issue=7&rft.spage=e267&rft.epage=e269&rft.pages=e267-e269&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.15834&rft_dat=%3Cproquest_cross%3E2676424873%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2676424873&rft_id=info:pmid/34363613&rfr_iscdi=true